GI Innovation Registers US Patent for Combination Therapy Including GI-101 and GI-102: Impact on Anticancer Drug Market
GI Innovation decides to register US patent for combination therapy including GI-101 and GI-102 (Provided by GI Innovation) [이데일리 김진호 기자]GI Innovation (358570) announced on the 15th that an additional U.S. patent has been registered for anti-cancer combination therapy including ‘GI-101’ or ‘GI-102’ discovered by the company. According to GI Innovation, this anticancer drug combination … Read more